Coronavirus vaccine, ODA and the need for transparency
OpinionEditorialJune 16, 2020
Plans are underway for an aid-financed mechanism, the Gavi Covax Advance Market Commitment (AMC), that would provide free or subsidised COVID19 vaccine to almost half the world’s population. Discussions about how it will work and how much it might end up costing have taken place largely behind closed doors. For an initiative that could well claim a significant share of a shrinking global ODA pot, necessarily taking funding away from other needs, the lack of transparency is worrying.
The rest of the content is only available for subscribers.